What is hilar cholangiocarcinoma?
Apr 21, 2023
Source: Cainiu Health
Dr. Jin Zhongkui
Introduction
Hilar cholangiocarcinoma is a malignant tumor originating in the biliary system at the hepatic hilum. In the early stages, it can be treated with partial hepatectomy or liver transplantation. For intermediate to advanced stages, chemotherapy drugs such as paclitaxel injection may be used under medical guidance. After diagnosis, patients should ensure adequate rest, sufficient sleep, and avoid excessive fatigue.
Hilar cholangiocarcinoma is a malignant tumor originating from the biliary system at the hepatic hilum, as detailed below:
The exact cause of hilar cholangiocarcinoma remains unclear, although it may be associated with long-term exposure to chemical toxins. Common symptoms during the course of the disease include loss of appetite, indigestion, jaundice, and abdominal pain. As the disease progresses, significant weight loss may occur. Prompt treatment is essential once diagnosis is confirmed, as delayed intervention may lead to tumor spread and metastasis, endangering life and health. In early stages, surgical treatments such as partial hepatectomy or liver transplantation may be performed. For intermediate or advanced stages, chemotherapy agents such as paclitaxel injection, cisplatin injection, and carboplatin injection may be used under medical supervision.
After diagnosis, patients should ensure adequate rest and avoid excessive fatigue. Maintaining a positive emotional state and avoiding undue stress are also important. During treatment, regular follow-up visits are necessary for imaging examinations such as ultrasound, CT, and MRI to monitor disease progression and assess treatment efficacy.
